Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced the purchase of equipment from Kelun Precision, a related company, for approximately RMB 6.24 million. The transaction, which is in compliance with listing rules and does not require shareholder approval, was agreed upon at arm’s length with the consideration deemed fair and reasonable by the directors. The deal will be financed with the company’s internal resources.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.

